Heparin-induced thrombocytopenia physical examination: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 9: Line 9:


===Skin Exam===
===Skin Exam===
* Skin necrosis from thrombotic physiology
* Skin necrosis from thrombotic physiology<ref name="pmid22315270">{{cite journal| author=Linkins LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S et al.| title=Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. | journal=Chest | year= 2012 | volume= 141 | issue= 2 Suppl | pages= e495S-e530S | pmid=22315270 | doi=10.1378/chest.11-2303 | pmc=3278058 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22315270  }} </ref>
* Petechiae from thrombocytopenia
* Petechiae from thrombocytopenia
* Purpura from thrombocytopenia
* Purpura from thrombocytopenia
Line 20: Line 20:


===Musculoskeletal Exam===
===Musculoskeletal Exam===
* Leg swelling from deep vein thrombosis
* Leg swelling from deep vein thrombosis<ref name="pmid22315270">{{cite journal| author=Linkins LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S et al.| title=Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. | journal=Chest | year= 2012 | volume= 141 | issue= 2 Suppl | pages= e495S-e530S | pmid=22315270 | doi=10.1378/chest.11-2303 | pmc=3278058 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22315270  }} </ref>
* Calf tenderness from deep vein thrombosis
* Calf tenderness from deep vein thrombosis



Revision as of 23:25, 14 July 2017

Heparin-induced thrombocytopenia

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Heparin-induced thrombocytopenia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Heparin-induced thrombocytopenia physical examination On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Heparin-induced thrombocytopenia physical examination

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Heparin-induced thrombocytopenia physical examination

CDC on Heparin-induced thrombocytopenia physical examination

Heparin-induced thrombocytopenia physical examination in the news

Blogs on Heparin-induced thrombocytopenia physical examination

Directions to Hospitals Treating Heparin-induced thrombocytopenia

Risk calculators and risk factors for Heparin-induced thrombocytopenia physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Shyam Patel [2]

Overview

Physical Examination

Skin Exam

  • Skin necrosis from thrombotic physiology[1]
  • Petechiae from thrombocytopenia
  • Purpura from thrombocytopenia
  • Ecchymoses from thrombocytopenia

Cardiopulmonary Exam

  • Tachypnea from pulmonary embolism
  • Tachycardia from pulmonary embolism
  • Hypoxia from pulmonary embolism

Musculoskeletal Exam

  • Leg swelling from deep vein thrombosis[1]
  • Calf tenderness from deep vein thrombosis

Other Exam Findings

  • Mucosal bleeding from thrombocytopenia (i.e. oral, nasal, urinary, menstrual, gastrointestinal, or other)
  • Abdominal tenderness from mesenteric venous thrombosis
  • Neurologic deficits from cerebral arterial or dural venous sinus thrombosis

Reference

  1. 1.0 1.1 Linkins LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S; et al. (2012). "Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines". Chest. 141 (2 Suppl): e495S–e530S. doi:10.1378/chest.11-2303. PMC 3278058. PMID 22315270.

Template:WS Template:WH